A prominent failure mechanism of small-diameter expanded polytetrafluoroethylene (ePTFE) vascular grafts is platelet-mediated thrombosis. We have designed surface modification for ePTFE consisting of a self-assembling fluorosurfactant polymer (FSP) bearing biologically active ligands, including adhesive peptides and polysaccharide moieties. The goal of this biomimetic construct is to improve graft hemocompatibility by promoting rapid surface endothelialization, while minimizing platelet adhesion. Here, we present a direct comparison of platelet and endothelial cell (EC) adhesion to FSPs presenting one of three cell adhesion peptides: cyclic Arg-Gly-Asp-D-Phe-Glu (cRGD), cyclic *Cys-Arg-Arg-Glu-Thr-Ala-Trp-Ala-Cys* (cRRE, *disulfide bond cyclization), linear Gly-Arg-Gly-Asp-Ser-Pro-Ala (RGD) or a polysaccharide moiety: oligomaltose (M-7), the later designed to prevent plasma protein adhesion. Measurements of soluble peptide-integrin binding indicated that cRRE exhibits the least affinity for the αIIbβ3 platelet fibrinogen receptor. Analysis of static and dynamic platelet adhesion on FSP modified surfaces demonstrated that both M-7 and cRRE promote significantly less platelet adhesion compared with RGD and cRGD FSPs, while EC adhesion was similar on all peptide FSPs and minimal on M-7 FSP. These results illustrate the potential for ligands presented in a FSP surface modification to selectively adhere ECs with limited platelet attachment.